FDA Inspection 1085302 — Enprani Co., Ltd.
The FDA completed an inspection of Enprani Co., Ltd. on March 15, 2019 in Jung. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 15, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jung (Korea (the Republic of))